Genotoxicity of goniothalamin in CHO cell line

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 562, Issue 1-2, 2004, Pages 91-102

  Umar Tsafe, Nasir ^a   Mohamed Said, Mohamed Saifulaman ^b   Rosli, Rozita ^a   Din, Laily Bin ^c   Lai, Leslie C ^d  

^a Universiti P   (Malaysia)

^b UNIVERSITI TEKNOLOGI MARA   (Malaysia)

^c UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

^d INTERNATIONAL MEDICAL UNIVERSITY   (Malaysia)

Author keywords

Annonaceae; Chromosome aberration; Genotoxicity; Goniothalamin; Goniothalamus umbrosus; Styrylpyrrone

Indexed keywords

BENZO[A]PYRENE; CLASTOGEN; GONIOTHALAMIN; MESYLIC ACID ETHYL ESTER; METHANE; METHYL GROUP; PLANT EXTRACT; TETRAZOLIUM; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CANCER CELL CULTURE; CHO CELL; CHROMOSOME ABERRATION; CHROMOSOME BREAKAGE; CONTROLLED STUDY; CYTOTOXICITY; DOSE RESPONSE; GENOTOXICITY; IC 50; METABOLIC ACTIVATION; METAPHASE; MITOSIS INDEX; NONHUMAN; PRIORITY JOURNAL; RING CHROMOSOME; SCREENING; STATISTICAL SIGNIFICANCE;

ANIMALS; BIOTRANSFORMATION; CHO CELLS; CRICETINAE; MITOSIS; MUTAGENICITY TESTS; MUTAGENS; PYRONES;

ANIMALIA; ANNONACEAE; GONIOTHALAMUS; GONIOTHALAMUS UMBROSUS;

EID: 3242802169     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mrgentox.2004.05.011     Document Type: Article

References (52)

1. S. Venitt, J.M. Parry, Background to mutagenicity testing, in: S. Venitt, J.M. Parry (Eds.), Mutagenicity Testing: A Practical Approach, IRL Press, Ltd., Oxford, 1984, pp. 1-24.
2. International Committee on Harmonization, Genotoxicity: guidance on specific aspects of regulatory genotoxicity tests for pharmaceuticals, ICH-3BS6a, 1995, pp. 51-62.
3. Organization for Economic Cooperation and Development, Guidelines for Testing of Chemicals, Genetic toxicology: in vitro mammalian chromosomal aberration test, Guideline no. 473, 1997, pp. 1-10.
4. Dearfield K.L., Cimino M.C., McCarroll N.E., Mauer I., Valcovic L.R. Genotoxicity risk assessment: a proposed classification strategy. Mutat. Res. 521:2002;121-135
5. L. Tomatis, Relation between mutagenesis, carcinogenesis and teratogenesis - experience from the IARC monographs programme, in: C. Ramel, B. Lambert, J. Magnusson (Eds.), Genetic Toxicology of Environmental Chemicals, Part B: Genetic Effects and Applied Mutagenesis, Proceedings of the Fourth International Conference on Environmental Mutagens, Stockholm, Sweden, June 24-28, 1985, Alan R. Liss, Inc., New York, 1986, pp. 3-12.
6. O'Brien P.J., Hales B.F., Josephy P.D., Castonguay A., Yamazoe Y., Guengerich F.P. Chemical carcinogenesis, mutagenesis and teratogenesis. Can. J. Physiol. Pharmacol. 74:1996;565-571
7. Dias F.D.L., Takahashi C.S. Cytogenetic evaluation of aqueous extracts of the medicinal plants Alpinia nutans Rose (Zingerberaceae) and Pogostemum hyneanus benth (Labitae) on Wistar rats and Allium cepa Linn (Liliaceae) root tip cells. Rev. Brasil Genet. 17:1994;175-180
8. Evans I.A., Osman M.A. Carcinogenicity of bracken and shikimic acid. Nature. 250:1974;348-349
9. Kangwanpong D., Arseculeratne S.N., Sirisinha S. Clastogenic effects of aqueous extracts of palmyrah (Borassus flabellifer) flour on human blood lymphocytes. Mutat. Res. 89:1981;63-68
10. Ames B.N., Gold L.S. Environmental pollution, pesticides and the prevention of cancer: misconceptions. FASEB J. 11:1997;1041-1052
11. Raskin I., Ribnicky D.M., Komarnysky S., Ilic N., Poulev A., Berisjuk N., Brinker A., Moreno D.A., Ripoll C., Yakoby N., O'Neal J.M., Cornwell T., Pastor I., Fridlender B. Plants and human health in the twenty-first century. Trends Biotech. 20:2002;522-541
12. Rates S.M.K. Plants as source of drugs. Toxicon. 39:2001;603-613
13. Ames B.N., Profet M., Gold L.S. Nature's chemicals and synthetic chemicals: comparative toxicology. Proc. Natl. Acad. Sci. USA. 87:1990;7782-7786
14. Ames B.N. Dietary carcinogens and anti-carcinogens. Science. 221:1983;1256-1264
15. Vargas V.M.F., Motta V.E.P., Leitao A.C., Heriques J.A.P. Mutagenic and genotoxic effects of aqueous extracts of Achyroline satureoides in prokaryotic organisms. Mutat. Res. 240:1990;13-18
16. Ames B.N., McCann J., Yamasaki E. Methods for detecting carcinogens and mutagens with the Salmonella/mammalian-microsome mutagenicity test. Mutat. Res. 31:1975;347-364
17. D.G. Gatehouse, I.R. Rowland, P. Wilcox, R.D. Callander, R. Forster, Bacterial mutation assays, in: D.J. Kirkland (Ed.), Basic Mutagenicity Tests: UKEMS Recommended Procedures, UKEMS/University of Cambridge Press, Cambridge, 1990, pp. 13-61.
18. Zimmerman F.K. Procedures used in the induction of mitotic recombination and mutation in the yeast Saccharomyces cerevisiae. Mutat. Res. 31:1975;71-86
19. Terziyska A., Waltschewa L., Venkov P. A new sensitive test based on yeast cells for studying environmental pollution. Environ. Pollution. 109:2000;43-52
20. I. de G. Mitchell, R.D. Combes, Mutation tests with the fruit fly Drosophila melanogaster, in: S. Venitt, J.M. Parry (Eds.), Mutagenicity Testing: A Practical Approach, IRL Press, Ltd., Oxford, 1984, pp. 149-185.
21. Grant W.F. Higher plant assays for the detection of chromosomal aberrations and gene mutations. Mutat. Res. 426:1999;107-112
22. B.J. Dean, N. Danford, Assays for the detection of chemically-induced chromosome damage in cultured mammalian cells, in: S. Venitt, J.M. Parry (Eds.), Mutagenicity Testing: A Practical Approach, IRL Press, Ltd., Oxford, 1984, pp. 187-232.
23. D. Scott, B.J. Dean, N.D. Danford, D.J. Kirkland, Metaphase chromosome aberration assays in vitro, in: D.J. Kirkland (Ed.), Basic Mutagenicity Tests: UKEMS Recommended Procedures, UKEMS/University of Cambridge Press, Cambridge, 1990, pp. 62-86.
24. E.J. Tawn, D. Holdsworth, The role of cytogenetics in the investigation of mutagen exposure and chromosome instability, in: D.E. Rooney, B.H. Czepulkowski (Eds.), Human Cytogenetics: Essential Data, John Wiley & Sons, Ltd., Chichester, 1994, pp. 102-110.
25. Preston R.J., Au W., Bender M.A., Brewen J.G., Carrano A.V., Heddle J.A., McFee A.F., Wolf S., Wassom J.S. Mammalian in vivo and in vitro cytogenetic assays. Mutat. Res. 87:1981;143-188
26. International Organization for Standardization, Biological evaluation of medical devices - Part 3: Tests for Genotoxicity, Carcinogenicity and Reproductive Toxicity, Second Working Draft for ISO/WD No. 10993-3, ISO, Munchen, Germany, 1997, pp. 1-20.
27. Ishidate M. Jr. A proposed battery of tests for the evaluation of the mutagenic potential of medicinal and industrial chemicals. Mutat. Res. 205:1988;397-407
28. Kirkland D.J. Report of the in vitro sub-group: International workshop on standardisation of genotoxicity test procedures. Mutat. Res. 312:1994;211-215
29. Adler I.A. A review of the coordinated research effort on the comparison of test systems for the detection of mutagenic effects, sponsored by the EEC. Mutat. Res. 74:1980;77-93
30. Burkill L.H., Haniff M. Malay village medicine. Garden's Bull. 6:1930;167-171
31. El-Sharkawi S., Yusuf Z., Pihie A.H.L., Ali A.M. Metabolism of goniothalamin in animal and microbial systems. Bull. Chim. Farmaceutica. 135:1996;35-40
32. Ali A.M., McKeen M.M., Hamidi M., Aun Q.B., Zauyah Y., Azimahtol H.L.P., Kawazu K. Cytotoxicity and electron microscopy of cell death induced by goniothalamin. Planta Medica. 63:1997;81-83
33. Pihie A.H.L., Stanslas J., Din L.B. Non-steroid receptor-mediated anti-proliferative activity of styrylpyrone derivative in human breast cancer cell lines. Anticancer Res. 18:1998;1739-1743
34. Ali A.M., Umar-Tsafe N., Mohamed S.M., Inayat-Hussein S.H., Oo K.T., Yusoff K., Osman A.B., Din L.B. Apoptosis induction in CEM-SS T-lymphoblastic leukemic cell line by goniothalamin. J. Biochem. Mol. Biol. Biophys. 5:2001;253-261
35. Inayat-Hussain S.H., Osman A.B., Din L.B., Ali A.M., Snowden R.T., MacFarlane M., Can K. Caspases-3 and -7 are activated in goniothalamin-induced apoptosis in human Jurkat T-cells. FEBS Lett. 456:1999;379-383
36. Lee A.T.C., Azimahtol H.L.P., Tan A.N. Styrylpyrone derivative (SPD) induces apoptosis in a caspase-7- dependent manner in the human breast cancer cell line MCF-7. Cancer Cell Int. 3(16):2003;1-8
37. Kabir K.E., Khan A.R., Mosaddik M.A. Goniothalamin - a potent mosquito larvicide from Bryonopsis laciniosa L. J. Appl. Ent. 127:2003;112-115
38. Knowles M. Report on Middle East and North Africa Regional Conference of Psychology. Int. Assoc. Appl. Psychol. Newslett. 16(2):2004;10
39. Azimahtol H.L.P., Munawer M., Din L.B. Anti-fertility effect of goniothalamin: a styrylpyrone isolated from Goniothalamus tapis Miq. Asia Pacific J. Pharmacol. 9:1994;273-277
40. S. Venitt, C. Crofton-Sleigh, R. Forster, Bacterial mutation assays using reverse mutation, in: S. Venitt, J.M. Parry (Eds.), Mutagenicity Testing: A Practical Approach. IRL Press, Ltd., Oxford, 1984, pp. 45-98.
41. Monks A., Scudiero D., Skehan P., Shoemaker R., Paull K., Vistica D., Hose C., Langky J., Cronise P., Vaigro-Wolf A., Gray-Goodrich M., Campbell H.J., Boyd M. Feasibility of high flux anticancer drug screen using a diverse panel of cultured human tumor cell lines. J. Natl. Cancer Inst. 83:1991;757-766
42. Mossman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63
43. Savage J.K.R. Classification and relationships of induced chromosomal structural changes. J. Med. Genet. 12:1975;103-122
44. Agrestri A. A survey of exact interference for contingency tables. Stat. Sci. 7:1992;131-153
45. UKEMS Sub-Committee on Guidelines for Mutagenicity Testing, Report - Part I, Basic Test Battery, United Kingdom Environmental Mutagen Society, Swansea, 1983, pp. 1-64.
46. W.B. Pratt, R.W. Ruddon, W.D. Ensminger, J. Maybaum, The Anticancer Drugs, second ed., Oxford University Press, Inc., New York, 1994, pp. 265-284.
47. I.F. Tannock, G.J. Goldenberg, Drug resistance and experimental chemotherapy, in: I.F. Tannock, R.P. Hill (Eds.), The Basic Science of Oncology, third ed., McGraw-Hill Book Co., Singapore, 1998, pp. 392-419.
48. Geran R.I., Greenberg N.H., McDonald M.M., Schumacher A.M., Abbott B.J. Protocols for screening chemical agents and natural products against animal tumour and other biological systems. Cancer Chemother. Rep. 3:1972;1-103
49. C. Richardson, D.A. Williams, G. Amplett, B. Phillips, J.A. Allen, D.O. Chanter, Analysis of data from in vitro cytogenetic assays, in: D.J. Kirkland (Ed.), Statistical Evaluation of Mutagenicity Test Data, UKEMS Sub-Committee on Guidelines for Mutagenicity Testing, Report - Part III, Cambridge University Press, Cambridge, 1989, pp. 41-154.
50. D.J. Brusick, Value of short-term mutagenicity tests in human population monitoring, in: K.C. Bora, G.R. Douglas, E.R. Nestmann, (Eds.), Chemical Mutagenesis, Human Population Monitoring and Genetic Risk Assessment, Progress in Mutation Research vol. 3, Elsevier Biomedical Press, Amsterdam-Oxford-New York, 1982, pp. 261-274.
51. Sam T.W., Chew S.-Y., Matsjeh S., Gan E.K., Razak D., Mohamed D.A.L. Goniothalamin oxide: an embryotoxic compound from Goniothalamus macrophyllus Annonaceae. Tetrahedron Lett. 28:1987;2541-2544
52. Bender M.A., Griggs H.G., Bedford J.S. Mechanisms of chromosomal aberration production III. Mutat. Res. 23:1974;197-212